Episodes 1-15 of 125
Ocular to Generalized MG: How and Why the Disease Evolves
MinuteCE®Ocular to Generalized MG: How and Why the Disease Evolves
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
MinuteCE®New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
MinuteCE®Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
MinuteCE®A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
MinuteCE®Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Managing Side Effects in FcRn Therapy: Best Practices for gMG
MinuteCE®Managing Side Effects in FcRn Therapy: Best Practices for gMG
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
MinuteCE®Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
MinuteCE®Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
MinuteCE®Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
CME/CETreatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Diagnostic Advances in gMG: Effective Tools and Techniques
MinuteCE®Diagnostic Advances in gMG: Effective Tools and Techniques
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
MinuteCE®Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
MinuteCE®Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs